---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-045844"
form_type: "8-K"
ticker: "TBPH"
cik: "0001583107"
company_name: "Theravance Biopharma, Inc."
filed_at: "2023-04-17T23:59:59+00:00"
generated_at: "2026-06-17T01:22:35.327245+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.0
calibrated_materiality_score: 0.0
confidence: "low"
source: SEC EDGAR
---

# Theravance Biopharma presents at Needham Healthcare Conference; no material news disclosed

## Summary
- Management team presented at 22nd Annual Needham Virtual Healthcare Conference on April 17, 2023.
- Slide deck furnished as Exhibit 99.1 contains only a title slide; no financial or pipeline updates provided.
- Filing under Item 7.01 is for Regulation FD purposes and is not deemed filed.

## SEC filing metadata
- accession: 0001104659-23-045844
- form_type: 8-K
- ticker: TBPH
- cik: 0001583107
- company_name: Theravance Biopharma, Inc.
- filed_at: 2023-04-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.0
- calibrated_materiality_score: 0.0
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583107/000110465923045844/0001104659-23-045844-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583107/000110465923045844/tm2312970d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-045844
- JSON: https://secwatch.observer/filing/0001104659-23-045844.json
- Plain text: https://secwatch.observer/filing/0001104659-23-045844.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.